NOD样受体蛋白3信号通路在变应性鼻结膜炎中的作用

doi:10.3969/j.issn.1006-5725.2024.14.004

Abstract

Abstract:

Objective The objective of this study was to establish a mouse model of allergic rhinoconjunctivitis and investigate the role of the NLRP3 signaling pathway in allergic rhinoconjunctivitis. Methods Thirty-three female C57 mice （SPF） were randomLy divided into 3 groups： the control group， the experimental group， and the NLRP3^-/- group. On days 0， 4， 7， 14， and 21， the experimental group and NLRP3^-/- group received a 0.2 mL intraperitoneal injection of medicine containing OVA （100 μg） and adjuvant Al（OH）₃ （4 mg）， respectively. After an interval of 3 days， each eye and nose were dosed with 10 μL of 5% OVA for five consecutive days a week to induce allergic symptoms. During sensitization and excitation stages， the control group was replaced with an equivalent amount of PBS. Ocular and nasal symptoms were observed and scored. The levels of OVA-specific IgE， IL-4， IL-17， and IL-18 in serum were measured using ELISA， while changes in palpebral conjunctiva and nasal mucosa were assessed by hematoxylin-eosin staining. The expression of NLRP3 mRNA in conjunctival tissue and nasal mucosa was determined using real-time PCR analysis. Statistical analysis was performed using SPSS17.0 software with P < 0.05 considered as statistically significant difference. Results The experimental group and NLRP3^-/- group exhibited induced nasal and ocular allergic symptoms. In the experimental group， the duration of nasal allergy symptoms was （10.500 ± 1.080） days， while the duration of eye allergy symptoms was （20.300 ± 2.058） days. In the NLRP3^-/- group， the duration of nasal allergy symptoms was （13.400 ± 1.955） days， and for eye allergy symptoms it was （20.900 ± 2.132） days. The duration of nasal allergies in the NLRP3^-/- group significantly exceeded that in the experimental group （P < 0.05）， whereas there were no significant differences observed in eye allergy durations between these two groups （P > 0.05）. Levels of OVA-specific IgE， IL-4， and IL-17 were significantly higher in both the experimental and NLRP3^-/- groups compared to those in the control group （P < 0.05）. Additionally， serum IL-18 content increased significantly in the experimental group when compared with both control and NLRP3^-/- groups （P < 0.05）. Conjunctival tissue lesions as well as nasal mucosa damage were evident in both experimental and NLRP3^-/- groups. mRNA expression levels of NLRP3 within conjunctival tissue and nasal mucosa from the experimental group showed a significant increase when compared to those from both control and NLRP3^-/- groups（P < 0.05）. Conclusion Allergic rhinoconjunctivitis pathogenesis is influenced by various factors； however， the involvement of NLPR3 signaling pathway promotes its development.

Key words: allergic rhinoconjunctivitis, ovalbumin, IgE, NLRP3

CLC Number:

R765.2

Yubo GONG,Xiaohua GUO,Wenjun LU,Yuanchao LI,Changyu QIU,Yuanyuan SHI,Liping XIA,Lin SHI,Wei WU,Ling. LUO. The role of NLRP3 signaling pathway in allergic rhinoconjunctivitis[J]. The Journal of Practical Medicine, 2024, 40(14): 1922-1927.

Figures/Tables 7

Tab. 1

Fig.1

Tab. 2

Fig.2

Tab. 3

Fig.3

Fig.4

References 25

1	BILANCIA M， PASCULLI G， DI BONA D. A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy［J］. PLoS One， 2020，15（5）：e0232753. doi:10.1371/journal.pone.0232753 doi: 10.1371/journal.pone.0232753
2	RATHINAM V A， FITZGERALD K A. Inflammasome Complexes： Emerging Mechanisms and Effector Functions［J］. Cell， 2016，165（4）：792-800. doi:10.1016/j.cell.2016.03.046 doi: 10.1016/j.cell.2016.03.046
3	宫玉波，石圆圆，李元超，等. 变应性鼻结膜炎模型小鼠的建立［J］. 中国组织工程研究， 2022，26（32）：5143-5147. doi:10.12307/2022.890 doi: 10.12307/2022.890
4	CIPRANDI G， LEONARDI S， ZICARI A M， et al. Allergic rhinoconjunctivitis： pathophysiological mechanism and new therapeutic approach［J］. Acta Biomed， 2020，91（1）：93-96.
5	邹昊宇，胡鸿运，刘嫡，等. 千里光通过NLRP3/Caspase-1/IL-1β通路对过敏性结膜炎大鼠角结膜炎症的影响［J］. 中药新药与临床药理， 2019，30（11）：1346-1351.
6	XIAO Y， XU W， SU W. NLRP3 inflammasome： A likely target for the treatment of allergic diseases［J］. Clin Exp Allergy， 2018，48（9）：1080-1091. doi:10.1111/cea.13190 doi: 10.1111/cea.13190
7	万慧娟. NLRP3炎性小体及下游因子IL-1β/IL-18在变应性鼻炎大鼠模型中的表达及意义［D］. 郑州：郑州大学， 2015. doi:10.3760/cma.j.issn.1673-0860.2015.02.011 doi: 10.3760/cma.j.issn.1673-0860.2015.02.011
8	YANG Z， LIANG C， WANG T， et al. NLRP3 inflammasome activation promotes the development of allergic rhinitis via epithelium pyroptosis［J］. Biochem Biophys Res Commun， 2020，522（1）：61-67. doi:10.1016/j.bbrc.2019.11.031 doi: 10.1016/j.bbrc.2019.11.031
9	LESZCZYŃSKA K， JAKUBCZYK D， GÓRSKA S. The NLRP3 inflammasome as a new target in respiratory disorders treatment［J］. Front Immunol， 2022，13：1006654. doi:10.3389/fimmu.2022.1006654 doi: 10.3389/fimmu.2022.1006654
10	潘徐彪，李向玉，王志鑫，等. NLRP3-（Caspase-1）/IL-1β信号通路的研究进展［J］. 中国医药导报， 2019，16（1）：41-44.
11	KIM J K， JIN H S， SUH H W， et al. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling［J］. Immunol Cell Biol， 2017，95（7）：584-592. doi:10.1038/icb.2017.23 doi: 10.1038/icb.2017.23
12	黄静，卢建峰，马萍. 中医药干预NLRP3炎症小体治疗相关疾病的研究进展［J］. 中药与临床， 2018，9（5）：57-60.
13	蒋丹露，刘阳阳，孙如愚，等. NLRP3炎症小体介导的炎症相关疾病研究进展［J］. 生命科学， 2017，29（9）：898-907. doi:10.13376/j.cbls/2017120 doi: 10.13376/j.cbls/2017120
14	OZAKI E， CAMPBELL M， DOYLE SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases： current perspectives［J］. J Inflamm Res， 2015，8：15-27. doi:10.2147/jir.s51250 doi: 10.2147/jir.s51250
15	陈永春，刘延刚，宗英，等. NLRP3炎症小体与相关系统疾病研究进展［J］. 北京医学， 2016，38（3）：263-265. doi:10.15932/j.0253-9713.2016.3.024 doi: 10.15932/j.0253-9713.2016.3.024
16	HERATH KHINM， CHO J， KIM H J， et al. Polyphenol containing Sargassum horneri attenuated Th2 differentiation in splenocytes of ovalbumin-sensitised mice： involvement of the transcription factors GATA3/STAT5/NLRP3 in Th2 polarization［J］. Pharm Biol， 2021，59（1）：1464-1472. doi:10.1080/13880209.2021.1992451 doi: 10.1080/13880209.2021.1992451
17	刘溪源，喻京生. 祛风明目丸对实验性自身免疫性葡萄膜炎大鼠NLRP3、ASC、IL-1β表达的影响［J］. 湖南中医药大学学报，2023，43（10）：1779-1785. doi:10.3969/j.issn.1674-070X.2023.10.005 doi: 10.3969/j.issn.1674-070X.2023.10.005
18	BRANDLI A， VESSEY K A， FLETCHER E L. The contribution of pattern recognition receptor signalling in the development of age related macular degeneration： the role of toll-like-receptors and the NLRP3-inflammasome［J］. J Neuroinflammation， 2024，21（1）：64. doi:10.1186/s12974-024-03055-1 doi: 10.1186/s12974-024-03055-1
19	BAI X， LIU P， SHEN H， et al. Water-extracted Lonicera japonica polysaccharide attenuates allergic rhinitis by regulating NLRP3-IL-17 signaling axis［J］. Carbohydr Polym， 2022，297：120053. doi:10.1016/j.carbpol.2022.120053 doi: 10.1016/j.carbpol.2022.120053
20	BAI M T， LI Y， HU Z L. Ragweed pollen induces allergic conjunctivitis immune tolerance in mice via regulation of the NF-κB signal pathway［J］. Int J Ophthalmol， 2021，14（7）：955-964. doi:10.18240/ijo.2021.07.01 doi: 10.18240/ijo.2021.07.01
21	WEATHERLY L M， SHANE H L， FRIEND S A， et al. Topical Application of the Antimicrobial Agent Triclosan Induces NLRP3 Inflammasome Activation and Mitochondrial Dysfunction［J］. Toxicol Sci， 2020，176（1）：147-161. doi:10.1093/toxsci/kfaa056 doi: 10.1093/toxsci/kfaa056
22	ZHANG W， BA G， TANG R， et al. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model［J］. Int Immunopharmacol， 2020，83：106394. doi:10.1016/j.intimp.2020.106394 doi: 10.1016/j.intimp.2020.106394
23	GUAN M， MA H， FAN X， et al. Dexamethasone alleviate allergic airway inflammation in mice by inhibiting the activation of NLRP3 inflammasome［J］. Int Immunopharmacol， 2020，78：106017. doi:10.1016/j.intimp.2019.106017 doi: 10.1016/j.intimp.2019.106017
24	KELLEY N， JELTEMA D， DUAN Y， et al. The NLRP3 Inflammasome： An Overview of Mechanisms of Activation and Regulation［J］. Int J Mol Sci， 2019，20（13）：3328. doi:10.3390/ijms20133328 doi: 10.3390/ijms20133328
25	XU S， WANG D， TAN L， et al. The role of NLRP3 inflammasome in type 2 inflammation related diseases［J］. Autoimmunity， 2024，57（1）：2310269. doi:10.1080/08916934.2024.2310269 doi: 10.1080/08916934.2024.2310269

组别	挠鼻次数	眼部分泌物
对照组	0.500 ± 0.535	0.125 ± 0.354
实验组	2.600 ± 0.516^*	2.100 ± 0.738^*
NLRP3^-/-组	2.500 ± 0.527^*	1.700 ± 0.675^*
F值	43.595	23.802
P值	0.000	0.000

组别	鼻部过敏出现时间	眼部过敏出现时间
实验组	10.500 ± 1.080	20.300 ± 2.058
NLRP3^-/-组	13.400 ± 1.955^*	20.900 ± 2.132
t值	-4.106	-0.640
P值	0.001	0.530

组别	OVA-sIgE（ng/mL）	IL-4（pg/mL）	IL-17（pg/mL）	IL-18（pg/mL）
对照组	18.368 ± 1.667	56.552 ± 3.781	24.298 ± 3.640	57.798 ± 2.547
实验组	29.890 ± 2.012^*	98.447 ± 6.870^*	37.882 ± 4.324^*	87.183 ± 2.451^*
NLRP3^-/-组	23.462 ± 1.912^*a	95.383 ± 17.728^*	34.638 ± 3.924^*	75.032 ± 6.196^*△
F值	84.585	86.505	19.132	191.645
P值	0.000	0.000	0.000	0.000

[1]	Rui ZHANG,Ying ZHOU,Wenji NI,Ya HUANG,Dandan LI,Tao JIN,Yong. ZHONG. Application value of artificial intelligence⁃basedretinal microvascular analysis in diagnosis of diabetes complications [J]. The Journal of Practical Medicine, 2024, 40(8): 1142-1147.
[2]	Liangjiang HUANG,Dewen MAO,Jinghui ZHENG,Minggang WANG,Chun YAO. Application of artificial intelligence in HE risk prediction modelling and research advances [J]. The Journal of Practical Medicine, 2024, 40(3): 289-294.
[3]	Linlin GAI,Weice SUN,Jinjin CHU,Donghua XU. Changes of M1/M2 macrophages polarization associated with active pulmonary tuberculosis and the effect of ESAT6 on macrophage polarization [J]. The Journal of Practical Medicine, 2024, 40(20): 2867-2873.
[4]	Jingfang WAN,Kehong. CHEN. Advances in research on optimal dialysate bicarbonate concentration for maintenance hemodialysis patients [J]. The Journal of Practical Medicine, 2024, 40(18): 2520-2524.
[5]	Qingdong YAO,Chengbing ZHANG,Jun FU,Peng WANG,Bin LONG,Haifeng. LIU. The correlation analysis of coronary artery plaque AI quantitative parameter with FFR-CT in coronary CT angiography [J]. The Journal of Practical Medicine, 2024, 40(17): 2489-2494.
[6]	Xiuli SHI,Jiaqi CHEN,Fan ZHU,Juan ZENG,Na. WU. The effect of miR⁃143⁃3p on pyroptosis of ulcerative colitis cells by regulating TLR2/NF⁃κB/NLRP3 [J]. The Journal of Practical Medicine, 2024, 40(15): 2056-2062.
[7]	Shuling SUN,Yuling XING,Jiangmei GONG,Ni. ZHANG. The relationship and clinical risk assessment between trigeminal nerve atrophy and pontine angle and recurrence after percutaneous radiofrequency thermocoagulation in ITN patients [J]. The Journal of Practical Medicine, 2024, 40(15): 2133-2137.
[8]	Jianjun LU,Yu HAN,Qiumin YU,Jiawen LIU,Minghua ZHU,Jinzhi LIN,Yang ZHANG,Yong ZHANG,Jinjian. WANG. Effects of transcranial direct current stimulation on sleep disorders in Parkinson′s disease： a randomized， single⁃blind controlled trial [J]. The Journal of Practical Medicine, 2024, 40(11): 1488-1493.
[9]	Mengni HU,Xiaolei ZHANG,Zhen RONG,Yao WANG,Ya′nan LI,Jun. MA. Effects of electroacupuncture on MPTP⁃induced FoXO1/NLRP3 pathway mediated neuroinflammation in mice with Parkinson′s disease [J]. The Journal of Practical Medicine, 2024, 40(11): 1494-1499.
[10]	Xizhi WEN,Xiaoshi. ZHANG. Immunotherapy based on neoantigen： A personalized treatment strategy for melanoma [J]. The Journal of Practical Medicine, 2024, 40(10): 1331-1337.
[11]	Linhui PENG,Dan LI,Zhiqiang HU,Xialin. ZUO. Connexin 43 hemichannel mediates NLRP3 inflammasome activation and its role in cerebral ischemia [J]. The Journal of Practical Medicine, 2024, 40(10): 1450-1454.
[12]	CHEN Fukun, LV Juan, DENG Zhiyong. Effect of chimeric antigen receptor gene⁃modified T⁃cell immunotherapy for lung cancer：A systematic review [J]. The Journal of Practical Medicine, 2023, 39(5): 538-543.
[13]	Qicheng JIN,Jianghong LV,Lilong XU,Hongfen WEI,Tongfang TANG,Chuanju ZHANG,Shiyan. LI. Impacts of different ultrasound imaging parameters on the differential diagnosis of benign and malignant breast nodules with S⁃Detect technology [J]. The Journal of Practical Medicine, 2023, 39(22): 2891-2897.
[14]	Yaoning SHAO,Fuxian XIE,Haiyang HUANG. The relationship of serum NLRP3 and PTEN expression with sex hormone level and semen quality in male infertile patients [J]. The Journal of Practical Medicine, 2023, 39(21): 2718-2722.
[15]	Xiangbing JIANG,Lifei WANG,Chunlin WU,Feng LI,Donghua WANG,Xuemei. GAO. Values of serum HE4 combined with exosome miRNA-200a/200b/200c in the early diagnosis of CA125 negative ovarian epithelial carcinoma [J]. The Journal of Practical Medicine, 2023, 39(19): 2541-2545.

The role of NLRP3 signaling pathway in allergic rhinoconjunctivitis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 7

References 25

Related Articles 15

Recommended Articles

Metrics

Comments